{
  "Variants Include": [
    {
      "Gene": "DJ1",
      "variants": [
        {
          "HGVS": "NM_007262.3:c.192G>C",
          "cDNA Change": {
            "transcript": "NM_007262.3",
            "ref": "G",
            "alt": "C",
            "position": "192"
          },
          "Protein Change": {
            "ref": "E",
            "alt": "D",
            "position": "64"
          },
          "Description in input context": "c.192G>C (p.E64D)"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Autosomal Recessive Early-Onset Parkinson Disease (PARK7)",
    "MONDO": "MONDO:0005320"
  },
  "Experiment Method": [
    {
      "Assay Method": "PET Imaging with [18F]FP-CIT",
      "Material used": {
        "Material Source": "Human subject",
        "Material Name": "Patient and control",
        "Description": "DAT binding in the striatum was measured using [18F]FP-CIT PET in a patient with the E64D mutation."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_007262.3:c.192G>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Reduced dopamine transporter (DAT) availability",
          "Result Description": "The patient showed reduced DAT binding in the striatum compared to controls."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "Not described in the literature."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "Not described in the literature."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "Not described in the literature."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "Not described in the literature."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Not specified in the literature."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Normal DAT binding levels in healthy controls (assumed standard for clinical PET imaging).",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Reduced DAT binding levels below 50% of control values (assumed standard for clinical PET imaging).",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Overexpression in HEK293 and COS7 Cells",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "HEK293 and COS7",
        "Description": "The E64D mutation was overexpressed in HEK293 and COS7 cells to assess protein levels and localization."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_007262.3:c.192G>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Reduced protein expression",
          "Result Description": "Overexpression of E64D showed reduced protein levels compared to wild-type."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "Not described in the literature."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "Not described in the literature."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "Not described in the literature."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "Not described in the literature."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Not specified in the literature."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Protein expression levels comparable to wild-type (assumed standard for overexpression studies).",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Protein expression levels reduced by 50% or more compared to wild-type (assumed standard for overexpression studies).",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Immunocytochemistry",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "HEK293 and COS7",
        "Description": "Immunocytochemistry was performed to assess the subcellular localization of the E64D mutant protein."
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "NM_007262.3:c.192G>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Altered protein localization",
          "Result Description": "E64D showed increased nuclear localization compared to wild-type, while L166P (a previously described mutant) showed similar localization to wild-type."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "Not described in the literature."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "Not described in the literature."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "Not described in the literature."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "Not described in the literature."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Not specified in the literature."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Wild-type localization patterns (assumed standard for immunocytochemistry).",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Significant deviation from wild-type localization patterns (assumed standard for immunocytochemistry).",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Crystallography",
      "Material used": {
        "Material Source": "Protein sample",
        "Material Name": "E64D mutant",
        "Description": "Crystallography was used to analyze the structural impact of the E64D mutation."
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "NM_007262.3:c.192G>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "No structural changes observed",
          "Result Description": "Crystallography did not reveal structural changes in the E64D mutant compared to wild-type."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "Not described in the literature."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "Not described in the literature."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "Not described in the literature."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "Not described in the literature."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Not specified in the literature."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Structural similarity to wild-type (assumed standard for crystallography).",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Structural differences detectable by crystallography (assumed standard for crystallography).",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}